HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ikeda, F. Articles by Yoneda, T. Search for Related Content PubMed PubMed Citation Articles by Ikeda, F. Articles by Yoneda, T.

Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity¹

Fumiyo Ikeda^2,*, Riko Nishimura^3,*, Takuma Matsubara^*, Kenji Hata^*, Sakamuri V. Reddy and Toshiyuki Yoneda^*

^* Department of Molecular and Cellular Biochemistry, Osaka University Graduate School of Dentistry, Osaka, Japan; and Children’s Research Institute, Medical University of South Carolina, Charleston, SC

The transcription factor family member NFAT plays an important role in the regulation of osteoclast differentiation. However, the role of NFAT in osteoclasts in vivo is still not fully understood. Thus, we generated transgenic mice in which constitutively active-NFAT1/NFATc2 (CA-NFAT1) is specifically expressed in the osteoclast lineage, using the tartrate-resistant acid phosphatase gene promoter. Both x-ray and histological analyses demonstrated an osteopenic bone phenotype in the CA-NFAT1 transgenic mice, whereas the number of tartrate-resistant acid phosphatase-positive osteoclasts was markedly higher in the long bones of these mice. Furthermore, the bone-resorbing activity of mature osteoclasts derived from the transgenic mice was much higher than that of wild-type mice. Interestingly, the introduction of CA-NFAT1 into osteoclasts or RAW264 cells increased the expression and activity of c-Src and stimulated actin ring formation. In contrast, CA-NFAT1 or GFP-tagged VIVIT peptide, a specific inhibitor of NFAT, did not affect the survival of mature osteoclasts. Collectively, our data indicate that NFAT controls bone resorption in vivo by stimulating the differentiation and functioning of osteoclasts but not their survival.

This article has been cited by other articles:

				T. Hikata, H. Takaishi, J. Takito, A. Hakozaki, M. Furukawa, S. Uchikawa, T. Kimura, Y. Okada, M. Matsumoto, A. Yoshimura, et al. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts Blood, March 5, 2009; 113(10): 2202 - 2212. [Abstract] [Full Text] [PDF]

				E. Canalis Notch Signaling in Osteoblasts Sci. Signal., April 29, 2008; 1(17): pe17 - pe17. [Abstract] [Full Text] [PDF]

				K. Kim, S.-H. Lee, J. Ha Kim, Y. Choi, and N. Kim NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Mol. Endocrinol., January 1, 2008; 22(1): 176 - 185. [Abstract] [Full Text] [PDF]

				H. Takayanagi Amazing Multifunctionality of Calcineurin and NFAT Signaling in Bone Homeostasis IBMS BoneKEy, September 1, 2006; 3(9): 28 - 31. [Full Text] [PDF]